Biopharma Plastics Market (2025 - 2035)

Biopharma Plastics Market Size and Share Forecast Outlook 2025 to 2035

The Biopharma Plastics Market is estimated to be valued at USD 6.7 billion in 2025 and is projected to reach USD 19.8 billion by 2035, registering a compound annual growth rate (CAGR) of 11.4% over the forecast period.

Quick Stats for Biopharma Plastics Market

• Biopharma Plastics Market Industry Value (2025): USD 6.7 billion
• Biopharma Plastics Market Forecast Value (2035): USD 19.8 billion
• Biopharma Plastics Market Forecast CAGR: 11.4%
• Leading Segment in Biopharma Plastics Market in 2025: Polyethylene – PE (48.6%)
• Key Growth Region in Biopharma Plastics Market: North America, Asia-Pacific, Europe
• Top Key Players in Biopharma Plastics Market: BASF SE, LyondellBasell Industries Holdings B.V., SABIC, LG Chem, Toray Industries, Inc., Solvay, Dow, Inc., DuPont de Nemours, Inc., Saint-Gobain Performance Plastics, Tekni-Plex, Chevron Phillips Chemical Co., LLC, Exxon Mobil Corporation, Formosa Plastics Corporation, Covestro AG, TEIJIN LIMITED, Mitsui & Co. Plastics Ltd., INEOS Group, CHIMEI

Metric	Value
Biopharma Plastics Market Estimated Value in (2025 E)	USD 6.7 billion
Biopharma Plastics Market Forecast Value in (2035 F)	USD 19.8 billion
Forecast CAGR (2025 to 2035)	11.4%

Rationale for Segmental Growth in the Biopharma Plastics Market

The biopharma plastics market is expanding rapidly due to the increasing demand for sterile, durable, and chemically resistant materials in pharmaceutical production and handling. The growth of biologics, personalized medicine, and complex drug formulations has necessitated advanced packaging and containment solutions that comply with strict regulatory standards.

Plastics offer critical benefits such as reduced contamination risk, lightweight properties, and compatibility with high precision molding for single use systems. The emphasis on operational efficiency and hygiene in biopharma processing is further boosting the use of disposable components including tubing, containers, and protective barriers.

Moreover, the growing adoption of automation and closed system bioprocessing has increased reliance on specialized polymers. The outlook remains positive as pharmaceutical manufacturers prioritize safety, flexibility, and scalability in production while meeting global compliance mandates.

Segmental Analysis

The market is segmented by Polymer Type and Application and region. By Polymer Type, the market is divided into Polyethylene – PE, Polypropylene – PP, Acrylonitrile Butadiene Styrene – ABS, Polyethylene Terephthalate – PET, Polyvinyl Chloride – PVC, Polytetrafluoroethylene – PTFE, and Other. In terms of Application, the market is classified into Protective Wear, Container, Bioreactor Bags, Syringes, Depth Filter, Disposable Medical Connectors, and Others. Regionally, the market is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.

Insights into the Polyethylene Polymer Type Segment

Polyethylene holds 48.60% of the total revenue in the polymer type category, establishing it as the leading segment. This dominance is attributed to its excellent chemical resistance, flexibility, and ease of processing which are essential in sterile pharmaceutical environments.

Polyethylene is widely used in the manufacturing of containers, tubing, films, and liners due to its low extractables and leachables profile, which ensures product purity and regulatory compliance. Its cost effectiveness and availability in various grades suitable for high purity applications have further contributed to its widespread adoption.

As the demand for reliable and compliant material solutions increases, polyethylene continues to be the preferred choice for critical applications across the biopharma value chain.

Insights into the Protective Wear Application Segment

Protective wear is projected to represent 42.30% of the total market revenue by 2025 under the application category, making it the dominant segment. This is driven by heightened safety standards in pharmaceutical manufacturing and the need for personal protection in sterile and cleanroom environments.

The use of plastic based protective wear such as gowns, gloves, masks, and aprons has become essential to prevent cross contamination and ensure compliance with GMP protocols. Increased production of biologics and vaccines, especially under accelerated timelines, has emphasized the importance of disposable and contamination free protective solutions.

As regulatory agencies tighten requirements for operator and product safety, demand for high quality protective wear continues to rise, reinforcing its position as the leading application in the biopharma plastics market.

2018 to 2022 Biopharma Plastics Sales Outlook Compared to Forecast from 2025 to 2035

The biopharma plastics market is expected to gain market growth in the forecast period of 2025 to 2035. Latest market analysis by FMI the market is to grow at a CAGR of 11.4% in the above-mentioned forecast period.

The COVID-19 pandemic has affected positively the Biopharma Plastics Market. During this pandemic, there was an immense requirement from the hospitals for biopharma plastic-based products such as syringes, gloves, and masks resulting in the surging demand for biopharma plastics polymers

The usage of biopharma plastics in various end-use industries is expanding as technology is developing all the time. Manufacturers are interested in investing in the research and development of biopharma plastics to boost the downstream usability of these materials in sectors such as healthcare, agriculture, packaging, and others.

Key Trends Influencing the Biopharma Plastics Market

Technological Advancements in Healthcare to boost the biopharma plastics market growth

Biopharma plastics are being utilized for providing higher stability to several applications including depth filters, syringes, and containers. Increased preference for use of high-grade polymers material in the construction of single-use biopharma plastics has fuelled the market growth.

Different types of polymer have several applications including depth filters, syringes, and containers. The market offers opportunities for the usage of a variety of polymer types such as PP, PE, PET, PTFE, and ABS as these polymer types are used for manufacturing biopharma plastic components including personal equipment (PPE), face masks, gloves, and gowns.

Increasing health concerns and growth in healthcare expenditure are expected to drive the market for biopharma plastics along with polymers. Moreover, the presence of large-scale PP molding facilities and the manufacturing sector is projected to propel the market growth over the forecast period. Industry leaders are investing heavily in Research and Development to provide biopharmaceutical products that suit every aspect of consumer needs, which is driving the biopharma plastics market.

Increasing Investments in Single-Use Products to drive the growth of the Global Biopharma Plastics Market

The increasing investments in single-use products for pharmaceutical processing are expected to fuel the growth of global biopharma plastics over the forecast period.

The global biopharma plastics market is being driven by prominent factors such as a rise in the incidence of chronic illnesses such as cancer and diabetes, as well as the increasing global adoption of single-use plastics.

Rapid advancements by prominent players toward constant innovations backed by technologies in the field of biopharmaceuticals act as one of the major factors strongly supporting the global growth of the biopharma plastics market.

Key Challenges Slowing Growth in the Biopharma Plastics Market

Although the biopharma plastics market has numerous end-uses, there are some obstacles that likely pose a challenge to market growth during the forecast period.

Patented production processes and high raw material costs have made it difficult for new companies to enter the biopharma plastics industry. The widespread accessibility of alternatives and strict regulatory environment is also hampering the biopharma plastics market growth.

North America Biopharma Plastics Market – Regional Performance Outlook

Increased advancement in medical technology to propel the market growth

North America is expected to register a CAGR of 11.6% in the biopharma plastics market, with the USA market for biopharma plastics contributing higher revenue, due to an increase in the number of healthcare facilities and advancements in medical technology.

The North American biopharma plastics market growth will be further fuelled by the increasing demand for these plastics in pharmaceutical packaging applications, itself due to the booming pharmaceutical industry in Canada. Additionally, many medical component and device manufacturers in the USA are adopting biopharma plastics in their products. Another significant element propelling the market in the nations is the existence of leading manufacturers and suppliers of medical-grade plastics.

The presence of key manufacturers of biopharma plastics such as Celanese Corporation, Eastman Chemical Co., and DuPont can be regarded as one of the leading factors driving the market in the country. Additionally, strong purchasing power coupled with high technological acceptance is a major factor for market growth in the region.

Europe Growth Potential in the Biopharma Plastics Industry

The Europe biopharma plastics market is expected to rise at a CAGR of 11.4% from 2025 to 2035. Europe is the second-largest shareholder in the market, mainly due to the growing political support and favorable reimbursement regulations for medical devices.

Additionally, updates to the region's medical device directives will improve the effectiveness, innovation potential, and safety of medical products. As a result, the demand for better medical devices would rise, which will likely have a favorable impact on the market.

Asia Pacific Role in Supporting Biopharma Plastics Market Expansion

Rapid development in pharmaceuticals to drive the market growth in Asia Pacific

Asia Pacific is likely to dominate the biopharma plastics market owing to rapidly growing industries in emerging economies such as India, China, and South Korea. Asia Pacific region has high demand and high manufacturing capacity due to the large population.

Asia-Pacific is expected to deliver impressive outcomes in the global biopharma plastics market. A large amount of investment, significant government meddling in the healthcare sector, and significant development in the developing economy all contribute to increased demand for biopharma plastics.

Furthermore, advancements in healthcare infrastructure, rising government spending on healthcare policies, and the presence of important members in Asia Pacific all contribute to the growth of the global biopharma plastics market.

Country-wise Forecast CAGR for the Biopharma Plastics Market

Country	CAGR
China	15.4%
India	14.3%
Germany	13.1%
France	12%
UK	10.8%
USA	9.7%
Brazil	8.6%

Biopharma Plastics Market Analysis by Resin Type and End Use

By Polymer Type, which segment generates high revenue in the Biopharma Plastics Market?

Polyvinyl chloride (PVC) dominated the market

Among all the polymer types polyvinyl chloride segment dominates the global market. Polyvinyl chloride accounted for more than 21.5% share of the overall revenue in 2025.

Polyvinyl chloride has the ability to undergo many processes without breaking or cracking, which accounts for its multiple uses in the market. It is extremely flexible, resistant, and can easily withstand high temperatures, making it suitable for the production of syringes, disposable connectors, depth filters, and other applications of biopharma plastics.

The presence of large-scale PP molding facilities and the manufacturing sector is projected to propel the market growth over the forecast period. Other polymer types such as polyethylene and polytetrafluoroethylene are mainly used in various applications owing to their properties such as gloss, durability, and detergent resistance all these factors are likely to boost market growth over the forecast period.

Based on Application Which Is the Most Prominent Segment in the Biopharma Plastics Market?

Syringes Segment remains dominant among other types

Based on application, the global biopharma plastics market can be categorized into Protective wear, Container, Bioreactor Bags, Syringes, Depth Filter, Disposable Medical Connectors, and Others. The syringes segment accounts for a market share of 20.2% through 2025. The Increasing demand for prefilled syringes owing to their usage convenience, low costs, minimal microbial contamination, low injection errors, and dilution errors is expected to boost the growth of the market.

Syringes are among the most popular healthcare products used by medical professionals to inject liquids and semi-solid compositions into the bodies of humans and animals. They are also used for withdrawing fluids as well for cleaning wounds or body cavities. The increased need for technically advanced healthcare and growing production of large molecules, and the rising expenditure for the development of advanced healthcare facilities are fueling the growth. The ease of usage and convenience offered by disposable biopharma plastic syringes boost the segment's growth.

Start-up Scenario in the Biopharma Plastics Industry

How do New Entrants Contribute to the Biopharma Plastics Market?

With technological innovations happening at a rapid pace, and companies looking for ways to increase customer engagement, start-ups are taking all possible steps to establish a name for themselves in the biopharma plastics market.

Some of the start-ups in the biopharma plastics market include-

• BluCon is a developer of bio-based and biodegradable thermoplastic. It offers PLA (polylactic acid) to replace petroleum-based plastics including polypropylene (PP), polyethylene (PE), polyethylene terephthalate (PET) & polystyrene (PS). It offers Lactic acid (2-hydroxy propionic acid) used in the food industry, chemical industry, pharmaceutical, and cosmetic products. The company collaborates with Shanghai Tong Jie Liang Biomaterials Ltd. (TJL) for the production of PLA.

Competitive Landscape of the Biopharma Plastics Market

BASF SE, LyondellBasell Industries Holdings B.V., SABIC, LG chem, Toray Industries, Inc., Solvay, Dow, Inc., DuPont de Nemours, Inc., Saint-Gobain Performance Plastics, Tekni-Plex are some of the key players in the biopharma plastics industry.

The manufacturers are involved in the production of biopharma plastics in a larger capacity. Research and innovation are also conducted to launch innovative plastics for biopharmaceutical products. Also, some of the key players are acquiring small pharmaceutical companies to increase their production capacity.

• In September 2025 - LyondellBasell announced today that Hanwha Solutions Corporation will use the LyondellBasell Lupotech T high-pressure polyethylene technology at a new site in Yeosu, South Korea. The Lupotech T process technology will be used for a 300 kiloton per year (KTA) vinyl acetate copolymer (EVA) line.
• In July 2025 - DuPont celebrated the opening of its new DuPont™ Liveo™ Healthcare Solutions manufacturing facility located at the Cooper River Site in South Carolina. The new facility will expand the capacity for biopharmaceutical tubing extrusion to meet increased demand from Liveo™ customers
• In October 2024 - Tekni-Plex Healthcare acquired precision extrusion manufacturer Johnson Plastic Group (JPG) as part of a strategy to expand the company’s patient care solutions platform. The acquisition expands Tekni-Plex Healthcare’s medical device capabilities and broadens the division’s global footprint by adding a presence in Mexico.
• In November 2025 - Solvay, a leading supplier of advanced materials, teamed up with French start-up Ostium in a joint project designed to enable the mechanical recycling of end-of-life single-use surgical instruments molded in glass-fiber reinforced Ixef® polyarylamide (PARA) from Solvay’s portfolio of specialty polymers.

Scope of the Biopharma Plastics Market Report

Report Attribute	Details
Growth Rate	CAGR of 11.4% from 2025 to 2035
Expected Market Value (2025)	USD 6.7 billion
Projected Forecast Value (2035)	USD 19.8 billion
Base Year for Estimation	2025
Historical Data	2020 to 2025
Forecast Period	2025 to 2035
Quantitative Units	Revenue in USD Million & CAGR from 2025 to 2035
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends & Pricing Analysis
Segments Covered	Polymer Type, Application, Regions
Regions Covered	North America; Latin America; Europe; Asia Pacific; Middle East & Africa
Key Countries Profiled	USA, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, China, Japan, South Korea, Singapore, Thailand, Indonesia, Australia, New Zealand, GCC Countries, South Africa, Israel
Key Companies Profiled	BASF SE; LyondellBasell Industries Holdings B.V.; SABIC; LG Chem; Toray Industries, Inc.; Solvay; Dow, Inc.; DuPont de Nemours, Inc.; Saint-Gobain Performance Plastics; Tekni-Plex; Chevron Phillips Chemical Co. Ltd.; ExxonMobil Corporation; Formosa Plastics Corporation; Covestro AG; TEIJIN LIMITED; Mitsui & Co. Plastics Ltd.; INEOS Group; CHIMEI
Customization	Available Upon Request

Top Investment Segments in the Biopharma Plastics Market Industry Survey

By Polymer Type:

• Polyethylene – PE
• Polypropylene – PP
• Acrylonitrile Butadiene Styrene – ABS
• Polyethylene Terephthalate – PET
• Polyvinyl Chloride – PVC
• Polytetrafluoroethylene – PTFE
• Other

By Application:

• Protective Wear
• Container
• Bioreactor Bags
• Syringes
• Depth Filter
• Disposable Medical Connectors
• Others

By Region:

• North America Biopharma Plastics Market
• Latin America Biopharma Plastics Market
• Europe Biopharma Plastics Market
• Asia Pacific Biopharma Plastics Market
• Middle East & Africa Biopharma Plastics Market